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Abstract
Bacteria belonging to the genus Cronobacter have been recognized as causative agents of
life-threatening systemic infections primarily in premature, low-birth weight and immune-
compromised neonates. Apparently not all Cronobacter species are linked to infantile
infections and it has been proposed that virulence varies among strains. Whole genome
comparisons and in silico analysis have proven to be powerful tools in elucidating potential
virulence determinants, the presence/absence of which may explain the differential viru-
lence behaviour of strains. However, validation of these factors has in the past been ham-
pered by the availability of a suitable neonatal animal model. In the present study we have
used zebrafish embryos to model Cronobacter infections in vivo using wild type and geneti-
cally engineered strains. Our experiments confirmed the role of the RepF1B-like plasmids
as “virulence plasmids” in Cronobacter and underpinned the importantce of two putative vir-
ulence factors—cpa and zpx—in in vivo pathogenesis. We propose that by using this model
in vivo infection studies are now possible on a large scale level which will boost the under-
standing on the virulence strategies employed by these pathogens.
Introduction
Cronobacter (C.) spp. are Gram-negative, rod-shaped, non- sporeforming, motile bacteria of
the family Enterobacteriaceae. The genus Cronobacter–as proposed in 2008 –currently consists
of seven species according to the “List of prokaryotic names with standing in nomenclature”
(http://www.bacterio.net/allnamesac.html, viewed, June 6th 2016) and encompasses organisms
that have previously been identified as Enterobacter sakazakii [1, 2]. The extension of the
genus Cronobacter by three non-pathogenic Enterobacter species (E. pulveris, E. helveticus and
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E. turicensis), as proposed by Brady et al. [3] was withdrawn as the genus membership was
experimentally disproved in the study by Stephan et al. [4].
Cronobacter spp. are regarded as opportunistic pathogens linked with life-threatening infec-
tions, particularly in premature (< 37 weeks of gestation stage), low-birth weight (< 2500 g) or
immuno-compromised neonates and infants less than 4 weeks of age [5, 6] and its occurrence
has been epidemiologically linked to the consumption of reconstituted intrinsically or extrin-
sically contaminated powdered infant formula (PIF) [7, 8].
Clinical symptoms include necrotising enterocolitis (NEC), bacteremia and meningitis,
with case fatality rates ranging between 40 and 80% being reported [9, 10].
Apparently not all Cronobacter species are linked to infantile infections and it has been pro-
posed that virulence varies among strains. Thus C. sakazakii, C.malonaticus, and C. turicensis
are the primary pathogenic species which cause the majority of severe illnesses neonates [11].
Some studies suggest that C.malonaticusmay be more of an adult pathogen than C. sakazakii
or C. turicensis are [12]. Other species of Cronobacter include C. universalis, C. condimenti, C.
muytjensii, and C. dublinensis. Except for C. condimenti, all other Cronobacter species cause a
variety of infections in humans [1, 7].
Applying a multilocus sequence typing scheme (MLST) to C. sakazakii strains revealed dis-
tinct pathovars which are clonal lineages of particular clinical significance, namely clonal coml-
pex 4 (CC4) that contains multilocus sequence type 4 (ST4), as well as ST12. These are strongly
associated with invasive meningitis and NEC cases. In addition, C.malonaticus clonal complex
7 was found to be linked with adult infections [7, 13, 14, 15].
Whole genome sequencing efforts and in silico analysis revealed a substantial amount of
genotypic variation and identified potential determinants encoding for potential virulence
determinants, present in some strains but absent in others which may explain that not all Cro-
nobacter spp. are equally virulent and cause invasive disease such as bacteremia and meningitis
[11, 16, 17]. However, the validation of putative virulence components has been hampered by
the availability of suitable neonatal animal models. So far, in vivo studies have concentrated on
the neonatal rat, mouse or gerbil as model organisms [17,18,19,20]. Although valuable infor-
mation has been obtained from these studies, the lack of possibilities for a real-time analysis
and the need for laborious and invasive sample analysis limits the use of mammalian experi-
mental animals.
Alternatively, the nematode Caenorhabditis elegans has been used to study Cronobacter vir-
ulence factors and host immune responses [21]. Thus, the role of the Cronobacter sakazakii
lipopolysaccharide (LPS) and the p38 MAPK pathway as a major factor in host immune
response against LPS-mediated challenges has been elucidated using this model [22]. However,
invertebrates are genetically not closely related to humans and their immune system shows
many differences from the human immune system.
Zebrafish (Danio rerio) are increasingly used as model to study infections with human path-
ogens as they offer distinct advantages over mammalian models, such as mice and rats or inver-
tebrate animal models such as the nematode C. elegans. Being vertebrates, zebrafish are
evolutionarily closer to humans than are nematodes and they are easier to work with and to
study than mice, but retain the advantage of a similar immune system [23]. The execution of
large-scale infection studies in zebrafish is possible due to their fecundity and small size. In a
recent study we adapted the zebrafish embryo model to study Cronobacter infections [24]. This
model proved especially useful, since in embryos only the innate immune system is displayed
which resembles the situation during infection in premature infants and neonates.
In the current study we employed the recently developed zebrafish embryo model to (1)
determine the virulence spectrum displayed among species and strains within the Cronobacter
genus, (2) define the role of the proposed “virulence plasmids”in Cronobacter spp. and (3)
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confirm the influence of two putative virulence determinants—the plasmid encoded Cpa and
the chromosomally encoded Zpx—in in vivo pathogenesis.
Material and Methods
Bacterial strains and culture conditions
The description of the wild type strains used in the study is given in Table 1. The two plasmid-
cured strains C. turicensis LMG 23827TΔpCTU1 and C. sakazakii ATCC BAA-894 ΔpESA3 were
constructed in the study by Franco et al. [25]. Those strains together with the C. sakazakii strain
E899, which is naturally devoid for the pESA3 plasmid were provided by CFSAN, FDA, USA.
Cronobacter spp. and E. coli strains were grown at 37°C in Luria-Bertani (LB) broth with shaking
(210 rpm) or on LB agar. Antibiotics were added when required at the following concentrations:
ampicillin (100 mg L-1), chloramphenicol (30 mg L-1 and nalidixic acid (256 mg L-1).
A nalidixic acid resistant strain of C. sakazakii ATCC BAA-894(Nal256) was constructed
according to the method by Johnson et al. [28]. Strain C. sakazakii ATCC BAA-894Δcpa was
created during transconjugation experiments and was consequently nalidixic acid resistant as
well. Both strains were used during quantitative zebrafish embryo infection experiments. Cul-
tures for experiments were grown in LB supplemented with nalidixic acid (256 mg L-1)
For microinjection experiments, the bacteria were grown to stationary phase in LB over-
night (approx. 12 hours) at 37°C, harvested by centrifugation at 5000 x g for 10 min and
washed once in 10 ml of Dubelcco`s phosphate buffered saline (DPBS, Life Technologies.)
After a second centrifugation step, the cells were resuspended in DPBS, and appropriate dilu-
tions were prepared in DPBS.
DNA extraction and manipulations
Chromosomal DNA was isolated using the DNeasy Blood and Tissue kit (Qiagen), plasmids
were extracted with the QIAprep Spin Miniprep or Plasmid Midi kits (Qiagen) following the
Table 1. Wild type strains used in the zebrafish embryo infection experiments.
Species Strain ID ATCCa LMGb, other* O typec Sequence typed Source and/or reference
Cronobacter condimenti LMG 26250T O1 98 Spiced meat [2]
Cronobacter dublinensis subsp. dublinensis LMG 23823T O1b 106 Milk powder processing environment [1]
Cronobacter dublinensis subsp. lactaridi LMG 23815 O1a 79 Milk powder processing environment [1]
Cronobacter dublinensis subsp. lausannensis LMG 23824 O2 80 Basin of a water fountain [1]
Cronobacter malonaticus LMG 23826T O2 7 Human breast abscess [1]
Cronobacter muytjensii ATCC 51329T O2 81 Unknown [1]
Cronobacter sakazakii ATCC 29544T O1 8 Child throat [1]
Cronobacter sakazakii ATCC BAA-894 O1 1 Milk powder [26]
Cronobacter sakazakii E899* O2 4 Clinical
Cronobacter turicensis LMG 23827T O1 19 Neonate [1]
Cronobacter universalis LMG 26249T O1 54 Water [1, 2]
Escherichia coli Xl1 blue n. a. n.a. Agilent
a: ATCC = American Type Culture Collection, Manassas, USA
b: LMG = BCCM/LMG Laboratorium voor Microbiologie, Universiteit Gent, Gent, Belgium
*: Type culture collection Institute for Food Safety and Hygiene, University Zurich, Zurich, Switzerland, O serotyped and MLST typed by Center for Food
Safety and Applied Nutrition FDA, Laurel, Maryland, USA
c, d: O (Sero)type and MLST Sequence type designations retrieved from Ogrodzki and Forsythe [27].
n. a.: not applicable
doi:10.1371/journal.pone.0158428.t001
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manufacturer’s instructions. For purification purposes (PCR, restriction digestion, agarose gel
purification) the Qiagen MinElute PCR Cleanup kit or MinElute Gel Purification kit was
employed. Enzymes and respective buffers were obtained from Roche Molecular Diagnostics
and used according to the manufacturer`s instructions.
Construction of C. turicensis LMG 23827TΔzpx and complementation
Bacterial strains, plasmids and primers used for the construction of the mutant are listed in
Table 2. An isogenic mutant of the C. turicensis LMG 23827T devoid of the zpx (CTU_31020)
gene was constructed following the protocol described by Philippe et al. [29]. Primers were
designed based on the whole genome sequence of Cronobacter turicensis LMG 23827T (RefSeq
accession numbers NC_013282 to NC_013285, GenBank accession numbers FN543093 to
FN543096). Briefly, two flanking fragments (upstream, downstream) of the zpx gene were
amplified by PCR using oligonucleotide primers zpxF1f (containing a XbaI recognition site),
Table 2. Material used for zpxmutant construction and complementation.
Strains/plasmids/primers Genotype/characteristic(s)/sequences Source or
reference
Mutant construction strains
C. turicensis LMG 23827T_NalR Acceptor for transconjugation, NalR [30]
E. coli SM10 λpir Host for pDS132::ΔrpfF, pDS132::ΔrpfR construct generation; thi, thr, leu, tonA lacY supE
recA::RP4-2-Tc::Mu, Km, λpir
[31]
E. coli DH5α λpir / pDS132 Host for cloning vector pDS132; sup E44, ΔlacU169 (Φ80lacZΔM15), recA1, endA1, hsdR17,
thi-1, gyrA96, relA1, λpir, CamR
[32]
E. coli SM10 λpir / pDS132::Δzpx Donor for transconjugation, harbouring construct pDS132::Δzpx, CamR This study
Plasmids
pDS132 Low copy cloning vector R6K ori,mobRP4, cat, sacB, CamR [29]
pDS132::Δzpx Δzpx cloned into pDS132, CamR This study
Primers
zpxF1f 5`- AGC TCT AGA AGC GGT CGG AAG AGC CTT TGG—3` This study
zpxF1r 5`- TAT CTC GAG GCC ATG ATC GAT AAT GCG GCG—3` This study
zpxF2fmod 5`- GGG CTC GAG GCT CAC TCT CGC AGA ATG CGG—3` This study
zpxF2r 5`- TGA TCT AGA GGT CTG GTG CTG GTT CAT ACC—3` This study
zpxConf 5`- CTA TAC TGC AAG TGT TGG—3` This study
zpxConr 5`- CGT CAT CCG TCA GAT CTG—3` This study
Complementation
C. turicensis LMG 23827T Template for ampliﬁcation of zpx CDS [33]
C. turicensis LMG 23827TΔzpx Zpx CDS mutant, cloning host for pQE-30, pQE-30::zpx This study
C. turicensis LMG 23827TΔzpx /
pQE-30
Mutant transformant harbouring expression cloning vector pQE-30, AmpR This study
C. turicensis LMG 23827TΔzpx /
pQE-30::zpx
Mutant transformant harbouring construct pQE-30::rpfF, AmpR This study
Plasmid
pQE-30 Cloning/expression vector, AmpR Qiagen
Primers
rpfFComplf 5`- AAA GCA TGC AAC CAG TCA CGT TAT CCA ACC- 3` This study
rpfFComplr 5`- AAA CCC GGG CGT CGG CGT CAT CCG TCA GAT CTG—3` This study
Insert control
pQE-30mcsf 5`- CGG ATA ACA ATT TCA CAC AG- 3` Qiagen
pQE-30r 5`- GTT CTG AGG TCA TTA CTG G- 3` Qiagen
doi:10.1371/journal.pone.0158428.t002
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zpxF1r (containing a XhoI restriction site), zpxF2fmod (containing a XhoI recognition site),
zpxF2r (containing a XbaI recognition site). The amplification mixes contained 0.4 μM of prim-
ers, 1 x AccuPrime (Invitrogen) buffer 2 (60 mM Tris-SO4 (pH 8.9), 18 mM (NH4)2SO4, 2 mM
MgSO4, 2 mM dGTP, 0.2 mM dATP, 0.2 mM dTTP, 0.2 mM dCTP, thermostable AccuPri-
meTM protein, 1% glycerol), 4% dimethylsulfoxid (DMSO), 2 U AccuPrime Taq DNA Poly-
merase High Fidelity (Invitrogen) and 50 ng of template DNA. Following PCR conditions were
used for the amplification: 95°C for 120 s followed by 34 cycles of 95°C for 30 s, 68°C for 270 s
and a final elongation step at 68°C for 300 s. The resulting fragments were digested with XbaI
and XhoI and ligated into the suicide vector pDS132 digested with XbaI. The construct
pDS132::Δzpx was transformed into E. coli SM10 λpir via electroporation. The resulting strain
E. coli SM10 λpir/ pDS132::Δzpx served as donor strain for conjugative transfer of the plasmid
into C. turicensis LMG 23827T_NalR. Transconjugants were selected on LB agar plates supple-
mented with both nalidixic acid 256 mg L-1 and chloramphenicol 30 mg L-1. The genetic struc-
ture of the mutant was confirmed by the presence of two amplification products—one
representing the chromosomal wild type zpx allele and a second product representing the trun-
cated (Δzpx) allele originating from the (integrated) pDS132::Δzpx—after PCR using primer
pair zpxContf, zpxContr employing the above mentioned AccuPrime amplification mixture
(without DMSO) and following amplification conditions: 95°C for 120 s followed by 32 cycles
of 95°C for 30 s, 52°C for 210 s and a final elongation step at 68°C for 300 s. The resulting ampli-
fication products were 1101 bp (wt zpx allel) and 240 bp (Δzpx allel).
Outcrossing was performed by plating serial dilutions of confirmed transconjugants onto
LB agar plates supplemented with 5% sucrose and no NaCl. Successful allelic exchange was ver-
ified in selected chloramphenicol sensitive and and sucrose resistant strains by the presence of
the mutant allele after PCR using the above mentioned procedure.
For complementation the zpx gene was amplified using primers zpxComplf and zpxComplr
(containing an SphI and XmaI site respectively) and using the above mentioned Accuprime
mixture (without DMSO) and following conditions: 95°C for 120 s followed by 32 cycles of
95°C for 30 s, 64°C for 30 s, 68°C for 120 s and a final elongation step at 68°C for 300 s. The
resulting fragments were cloned into pQE-30 expression vector and the resulting plasmid
pQE-30::zpx transformed into E. coli Xl1blue or C. turicensis LMG 23827TΔzpx.
Construction of C. sakazakii ATCC BAA-894Δcpa and complementation
The construction of the cpa isogenic mutant, was completed according to the method pub-
lished by Franco et al. [34]. For complementation experiments, the cpa was cloned into pQE-
30 expression vector (Qiagen) by PCR amplification using the primers XmaI, (5`- AAA CCC
GGG AAT AAG AAA CTT ATT GTC GTG GCG- 3`) and SalI, (5`- AAA GTC GAC AAC CCG
CCG GCA GCG GG- 3`). The recombinant plasmid was transformed into E. coli Xl1blue or C.
sakazakii ATCC BAA-894Δcpa.
Zebrafish infection studies
Zebrafish (Danio rerio) strains used in this study were albino lines. Husbandry, breeding and
microinjection of approx. 50 CFU of bacteria into the yolk sac of 2 dpf embryos was performed
following the procedure described in the study by Fehr et al. [24]. A total of thirty embryos (10
x 3) were injected per individual experiment (i.e. per strain).
A set of uninjected embryos, incubated in E3 maintenance medium (5 mMNaCl, 0.17 mM
KCl, 0.33 mM CaCl2, 0.33 mMMgSO4) was included in order to determine the quality of the
embryos; embryos injected with DPBS served as controls. Prior to injection, embryos were
manually dechorionated and anesthetized with 200 mg L-1 buffered tricaine (Sigma-Aldrich).
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After injection, the infected embryos were allowed to recover in a petri dish with fresh E3
medium for 15 min. Injected embryos were transferred into 24-well plates (1 embryo per well)
in 1 ml E3 medium per well, incubated at 28°C and inspected for survival under a stereomicro-
scope. At regular time points after infection, the number of dead larvae was determined visually
based on the absence of a heartbeat. Experiments were carried out until 96 hours post infection
(hpi). Surviving embryos were euthanized with an overdose of 4 g L-1 buffered tricaine at the
end of the experiments. Generally, with the assessment of discomfort and pain by behavioral
observations, animals were euthanized by overdose of tricaine by prolonged immersion and
were left in the solution for at least 10 minutes following cessation of opercular movement.
Since pain perception has not been developed at these earlier stages (4 dpf– 7 dpf), this is not
considered a painful procedure.
The maximum age reached by the embryos during experimentation was 144 hpf. Embryos
had not reached free feeding stage then. In addition, research was conducted with approval
(NO 216/2012) from the Veterinary Office, Public Health Department, Canton of Zurich
(Switzerland) allowing experiments with embryos and larvae older than 120 dpf. The applied
methods were carried out following the approved guidelines.
Survival assay
Thirty 2 dpf embryos were microinjected as mentioned above and maintained individually in
24-well plates in E3 medium at 28°C. Growth behaviour of strains C. sakazakii ATCC BAA-
894 and C. sakazakii ATCC BAA-894Δcpa was monitored until 72 hpi.
Bacterial enumeration by plate counting
The larvae were transferred to 1.5 ml centrifuge tubes and disintegrated by repeated pipetting
and vortexing for 3 min in 1 mL of DPBS supplemented with 1% Triton X- 100 (Sigma-
Aldrich). Subsequently, serial dilutions of this mixture were plated onto LB plates supple-
mented with 256 mg L-1 nalidixic acid. The plates were incubated up to 48 h at 37°C.
Statistical analysis
Kaplan Meier survival analysis, log rank (Mantel-Cox) test and graphs were performed using
GraphPad Prism 6 (GraphPad Software, San Diego, USA). Experiments were executed in tripli-
cates (i.e. 10 embryos x 3 per bacterial strain).
Results
Pathogenicity varies within the Cronobacter genus and among strains
Infection experiments using 10 strains—the type strains of the 7 species and 2 subspecies
within the Cronobacter genus plus one additional C. sakazakii strain ATCC BAA-894—
revealed a substantial degree of variation as determined from the mortality rate in the embryos.
Hundred per cent mortality was observed within 36 hours post inoculation (hpi) in infection
experiments using C. sakazakii ATCC 29544T and C. turicensis LMG 23827T (Fig 1A and 1B).
This rate was also reached during experiments using C. universalisNCT9529T and C. dublinen-
sis ssp. dublinensis LMG 23823T although although death of the embryos occurred at a later
time point (72 hpi). For C. sakazakii ATCC BAA-894 the highest mortality rate (82%) was
reached at 96 hpi. Also eighty per cent mortality was observed for C.malonaticus LMG23826T,
C. dublinensis ssp. lactaridi LMG 23825 and C. condimenti LMG 26249T at 96 hpi. For C. dubli-
nensis ssp. lausannensis LMG 23824 infection experiments, a 40% mortality rate was observed
at 96 hpi and C.muytjensii ATCC 51329T was completely avirulent (Fig 1A and 1B).
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The role of pESA3 and pCTU1 as “virulence plasmids” is confirmed in
vivo
In one of the first comparative genomics studies performed on whole genomes available for the
two Cronobacter species C. sakazakii ATCC BAA-894 and C. turicensis z3032 (= LMG 23827T)
by Franco et al. [25] it was reported that multiple plasmids were present in the strains including
two homologous plasmids identified as pESA3 in C. sakazakii BAA-894 and pCTU1 in C. turi-
censis LMG 23827T. In silico analysis revealed that both plasmids encode similar groups of
genes or gene clusters comprising the “backbone”of the plasmid, the same RepFIB-like origin
of replication gene (repA), two iron acquisition systems, an aerobactin-like siderophore
(named cronobactin), and an ABC ferric-iron transporter gene cluster, as well as several spe-
cies-specific virulence gene determinants. It has been proposed that these plasmids may repre-
sent “virulence plasmids”conferring virulence to Cronobacter isolates.
In order to test the hypothesis that these RepFIB-like plasmids harbored by Cronobacter
spp. are involved in pathogenesis, zebrafish embryo infection studies were performed using the
plasmid cured strains of C. turicensis LMG 23827TΔpCTU1 and C. sakazakii ATCC BAA-
894ΔpESA3. As can be retrieved from Fig 2, the mortality of both plasmid-cured strains was
considerably reduced compared to the results obtained with the wild type strains. In addition,
when using C. sakazakii strain E899, which is naturally devoid of the pESA3 homologue in
infection experiments, a maximum mortality rate of 20% was recorded at 96 hpi.
The two putative virulence factors Cpa and Zpx play a role in in vivo
pathogenesis
In two studies by Franco et al. [25, 34], C. sakazakii plasmid pESA3 was shown to encode the
putative virulence factor Cronobacter plasminogen activator (cpa) gene locus. It was demon-
strated that the outer membrane protease Cpa provides serum resistance to C. sakazakii ATCC
BAA-894 by proteolytically cleaving complement components, as well as by activating plas-
minogen and inactivating the plasmin inhibitor α2-AP. To test its influence in an in vivo
model a knock out mutant (ATCC BAA-894Δcpa) was constructed and tested together with
the wild type strain and ATCC BAA-894Δcpa complemented with the cpa gene in trans in the
zebrafish embryo model. In addition, E. coli Xl1blue carrying the Cpa determinant in trans was
included in the experiments. As shown in Fig 3, C. sakazakii ATCC BAA-894Δcpa displayed
only 10% mortality compared to 80% mortality observed in experiments with the wild type
parental strain. Virulence was partially restored to 40% with the complemented mutant. In
Fig 1. A, B. Zebrafish embryo infection experiments performed withCronobacterwt strains. n = 30 embryos per strain, p = < 0.0001.
doi:10.1371/journal.pone.0158428.g001
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addition, infection experiments using E. coli Xl1blue carrying the Cpa determinant displayed a
moderately elevated mortality rate (20%) when compared to E. coli wild type strain.
In order to obtain more quatitative kinetic information on the progression of the infection,
growth experiments using the BAA-894 wt and cpamutant (Fig 4) were carried out. Growth of
the strains in the zebrafish embryo model was comparable until 24 hpi when growth slowed in
the mutant and then at 48 hpi a sharp drop was observed in the bacterial counts of the mutant
suggesting that the embryos were able to clear the infection. Growth curves in LB grown cul-
tures suggested no growth defect in the mutant (S1 Fig).
Another putative virulence factor, the zinc containing metalloprotease zpx, was described
by Kothary et al. [35]. In contrast to the above mentioned Cpa determinant, the zpx locus is
Fig 3. Infection experiments using theC. sakazakii ATCC BAA-894 wt, the cpamutant and control strains. n = 30 embryos per strain,
p < 0.0001.
doi:10.1371/journal.pone.0158428.g003
Fig 2. Infection experiments usingC. turicensis LMG 23827T,C. sakazakiiATCCBAA-894 wt, the (pESA3, pCTU1) plasmid-cured
strains, andC. sakazakii E899 strain naturally devoid of the pESA3 plasmid. n = 30 per strain, p = 0.0007.
doi:10.1371/journal.pone.0158428.g002
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chromosomally encoded and is supposed to be present in all Cronobacter species [31, 4].
Although activity of this protease against Chinese hamster ovary cells (CHO) in tissue culture
has been reported, its contribution to virulence has never been tested before. A zpxmutant strain
was constructed in C. turicensis LMG 23827T and tested in the zebrafish embryo infection model
together with its wild type, the complemented mutant and an E. coli Xl1blue strain carrying the
Zpx determinant. The results of these experiments are depicted in Fig 5. The mortality rate in the
Fig 4. Quantitative infection experiments usingC. sakazakiiATCCBAA-894 wt and the cpamutant.
doi:10.1371/journal.pone.0158428.g004
Fig 5. Infection experiments using theC. sakazakii ATCCBAA-894 wt, the zpxmutant and control strains. n = 30 embryos per strain,
p < 0.0001.
doi:10.1371/journal.pone.0158428.g005
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C. turicensis LMG 23827T Δzpxmutant was diminished by 60% and in experiments using the
complemented mutant virulence was restored to a large extent (80%). As expected, the mortality
rate using the E. coli Xl1blue harbouring the zpx locus was also elevated to 70%, thus underpin-
ning the role of this important viulence factor in Cronobacter spp. disease.
Discussion
The results presented in this study may to some extent be correlated to the “clade theory”pro-
posed by Grim et al. [36]. According to this hypothesis, Cronobacter have diverged into two
clades, one consisting of C. dublinensis and C.muytjensii (Cdub-Cmuy) and the other com-
prised of C. sakazakii, C.malonaticus, C. universalis, and C. turicensis, (Csak-Cmal-Cuni-Ctur)
from the most recent common ancestral species. It was shown, that the Cdub-Cmuy clade
genomes contained several accessory genomic regions important for survival in a plant-associ-
ated environmental niche, while the Csak-Cmal-Cuni-Ctur clade genomes harbored numerous
virulence-related genetic traits.
However, mortality rates such as seen with C. dublinensis ssp. dublinensis LMG 23825T,
which is supposed to be a member of the “environmental/plant associated (Cdub-Cmuy) cla-
de”but exhibiting an equally high mortality rate as the putative “virulence associated (Csak-
Cmal-Cuni-Ctur) clade”members suggests, that additional virulence factors may exist, which
are more crucial for the pathogenesis/mortality (at least in this model) than others. Whole
genome comparisons are currently needed in order to elucidate other potential factors that
may contribute to the highly virulent phenotype observed for this strain in our model.
One striking result was the finding that infection studies performed with the C.muytjensii
ATCC 51329T type strain resulted in zero mortality. It has been previously reported that this
strain does not harbor a RepFIB-like “virulence plasmid”[25]. The results from our experi-
ments suggest that the presence of the these plasmid strongly contributes to virulence. Our
experiments using the plasmid-cured strains compared to parental wt strains underpinned the
role of these plasmids in virulence, as mortality rates were reduced by approx. half in the plas-
mid-cured strains C. sakazakii BAA-894 and C. turicensis LMG 23827T. However, these strains
did not become completely avirulent, again suggesting the presence of additional factors which
contribute to pathogencity.
In silico analysis of pESA3 and pCTU1 revealed a high degree of similarity concerning the
presence of putative virulence genes and gene clusters. However, it has also been shown, that
particular virulence factors are exclusively found along species-specific evolutionary lines [25].
One of those factors—the Cronobacter plasminogen activator Cpa—is encoded by pESA3 and
was demonstrated to be present in C. sakazakii strains [34]. This factor is supposed to play an
important role in survival of the bacterium in the blood. Our results from the infection experi-
ments using the isogenic cpamutant confirmed an important role of this determinant in in
vivo pathogenesis. From previous studies we know, that Cronobacter is not capable to replicate
in blood [37] thus, for infection studies in zebrafish, bacteria have to be injected into the yolk
saculum where they start to proliferate before traversing into the blood followed by dissemina-
tion into embryonic tissues- causing fatal bacteremia [20]. When we perfomed quantitative
growth experiments in embryos using wt and cpamutant we observed equal growth behaviour
for both strains until 48 hpi. However, at later time points the bacterial counts decreased signif-
icantly in infections with the cpamutant. We hypothesize that at time points> 48 h post infec-
tion the bacterium had already transversed into the blood where a mutant deficient of the cpa
determinant was efficiently eliminated by the host immune system.
In conclusion, we show, that the zebrafish embryo infection model is an extremely useful
tool to study the contributions of putative virulence factors whether they have been derived by
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in silico analysis or from previous in situ experiments. The potential of this model for use in
large scale infection studies holds much promise in improving the understanding of the viru-
lence potential of these pathogens.
Supporting Information
S1 Fig. Growth curves of the C. sakazakii ATCC BAA-894 wt and the cpamutant gown in
LB. Bacterial growth was monitored over 24 h at 37°C at 600 nm in 200 μl volumes of medium
in 96 well plates using the Bio-Tek microplate reader (Synergy HT; Bio-Tek, Germany).
(TIF)
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